North America Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Botulinum toxin A and Botulinum toxin B), Application (Medical and Aesthetic), and End User (Speciality and Dermatology Clinics, Hospitals and C

North America Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Botulinum toxin A and Botulinum toxin B), Application (Medical and Aesthetic), and End User (Speciality and Dermatology Clinics, Hospitals and Clinics, and Others)

The North America botulinum toxin market is expected to reach US$ 5,044.5 million by 2028 from US$ 2,897.5 million in 2021. The market is estimated to rise at a CAGR of 8.2% from 2021 to 2028.

According to the American Society of Plastic Surgeons (ASPS), in 2019, the total number of cosmetic procedures in India was 643,752, out of which nonsurgical procedures were 249,024. Among these, botulinum toxin procedures accounted for a total of 70,248 procedures. Similarly, in 2019, the total number of cosmetic procedures performed in Brazil was 2,565,675, of which nonsurgical procedures totaled 1,072,002, and among them, botulinum toxin procedures were 507,869.

Therapeutic uses of BTX include treating various diseases, such as chronic migraines, muscle spasticity, over-reactive bladder, and hyperhidrosis. The cosmetic and clinical application of BTX offers a comprehensive and in-depth review of aesthetic procedures and medical applications for standalone treatment and combination therapy. Thus, with the rise in the number of aesthetic service providers, practitioners, and plastic surgeons, aesthetic procedures have gained significant momentum in North America, thereby boosting the demand and sales of botulinum toxin, contributing to the North America botulinum toxin market.

With these new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the botulinum toxin market at a substantial CAGR during the forecast period.

North America Botulinum Toxin Market Revenue and Forecast to 2028 (US$ Million)

North America Botulinum Toxin Market Segmentation

By Product Type

Type A Botulinum Toxin Type B Botulinum Toxin

By Application

Medical Chronic Migraine Muscle Spasm Over Reactive Bladder Hyperhidrosis Others Aesthetic Crow’s Feet Forehead Lines Frown Lines/ Glabellar Square Jaw/ Masseter Others

By End-User

Specialty And Dermatology Clinics Hospitals And Clinics Others

By Country

North America US Canada Mexico

Companies Mentioned

Abb Vie Inc. Merz Pharma Medytox Sanofi Ipsen Pharma Galderma Revance Therapeutics Inc. Lanzhou Institute of Biological Products Co., Ltd. Candela Medical Daewoong Pharmaceutical Co. Ltd.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America botulinum toxin market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America botulinum toxin market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.